Pfizer Inc. (PFZ)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

$ 29.13
   
  • Change Today:
    $0.00
  • 52 Week High: $30.9
  • 52 Week Low: $21.5
  • Currency: US Dollars
  • Shares Issued: 7,066m
  • Volume: 0
  • Market Cap: $205,827m
  • Beta: 0.43

Pfizer Inc. Overview

In 1849, Charles Pfizer & Company opened as a fine-chemicals business. Now, as a research-based, global pharmaceutical company, Pfizer is the world's largest company devoted to healthcare, with products available in more than 150 countries. In June 2000, Pfizer completed the acquisition of Warner-Lambert, creating the world's most valuable and fastest-growing pharmaceutical company, and, in April 2003, merged with Pharmacia Corporation, enlarging Pfizer's portfolio of consumer healthcare brands and expanding its animal health business.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 3.0% 3.3%
Div Cover n/a 2.3
Op Mrgn n/a 38.5%
ROCE n/a  
Latest F'cast
P/E 22.9 13.1
PEG n/a 0.2
Pr/Revenue 3.5 3.6
Pr/Book 2.5  
Latest F'cast
Revenue n/a -3.9%
PBT 37.5% 80.6%
EPS n/a 75.5%
DPS n/a 8.2%

Pfizer Inc. Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 48,296.00 9,694.00 242.00¢ 4.9 0.0 +105% 128.00¢ 10.8%
31-Dec-09 50,009.00 10,827.00 202.00¢ 9.1 n/a -16% 80.00¢ 4.3%
31-Dec-10 67,057.00 9,282.00 222.00¢ 7.8 0.8 +10% 72.00¢ 4.1%
31-Dec-11 65,259.00 12,304.00 107.00¢ 20.6 n/a -52% 80.00¢ 3.6%
31-Dec-12 58,986.00 12,080.00 127.00¢ 19.4 1.0 +19% 88.00¢ 3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Pfizer Inc. Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 56,663.41 21,819.11 222.83¢ 13.1 0.2 +76% 95.19¢ 3.3%
31-Dec-14 55,721.91 22,062.83 235.54¢ 12.4 2.2 +6% 102.50¢ 3.5%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

Pfizer Inc. Company Announcements

Partners Pfizer for over-the-counter Nexium 14-Aug-2012 07:00 RNS
Pfizer License Extension 04-May-2011 07:00 RNS
Pfizer Announces New $5 Billion Share Repurchase... 01-Feb-2011 13:01 Business Wire

Pfizer Inc. ShareCast News

Astra raises guidance after Pfizer OTC tie-up 14-Aug-2012 ShareCast

Pfizer Inc. Motley Fool Analysis & Commentary

Can GlaxoSmithKline Outperform Pfizer? 2013--15 Motley Fool

Pfizer Inc. Top Newspaper Links

Pfizer hit with $60m bribery bill 22-Nov-2011 The Independent
Pfizer to buy pain drug maker Icagen for $56m 21-Jul-2011 Telegraph
Britain's reputation as pharmaceutical centre le... 07-Feb-2011 Daily Mail

Latest Pfizer Inc. Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Pfizer Inc. Market Data

Currency US Dollars
Share Price $ 29.13
Change Today $ 0.00
% Change 0.00 %
52 Week High $30.9
52 Week Low $21.5
Volume 0
Shares Issued 7,066m
Market Cap $205,827m
Beta 0.43

Pfizer Inc. Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.77% above the market average8.77% above the market average8.77% above the market average8.77% above the market average8.77% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Price Trend
3.81% above the market average3.81% above the market average3.81% above the market average3.81% above the market average3.81% above the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average
Income
13.05% above the market average13.05% above the market average13.05% above the market average13.05% above the market average13.05% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Growth
5.59% above the market average5.59% above the market average5.59% above the market average5.59% above the market average5.59% above the market average
12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average

What The Brokers Say

Strong Buy 12
Buy 4
Neutral 5
Sell 0
Strong Sell 0
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Pfizer Inc. Dividends

  Latest Previous
  Q1
Ex-Div n/a
Paid n/a
Amount 24.00¢

Trades for --2013

Time Volume / Share Price
0 @ $0.00

Top of Page